Back to top
Live:
Coronavirus Updates

Researchers at the biotechnology company Novavax have begun enrollment in a clinical trial of a coronavirus vaccine called NVX-CoV2373. The vaccine will be tested in the trial's Phase 1 portion for safety and immunogenicity, which is its ability to provoke an immune response in the body.

If the results of the trial show promise, Phase 2 testing will follow later in the summer.

NVX-CoV2373 is a vaccine engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19. It contains an antigen derived from the coronavirus spike protein, a viral protein highly recognized by the body's immune system. It also contains Matrix-M™, an adjuvant created by Novavax used to enhance the body's immune system's reaction to the vaccine.

In preliminary testing of animal models, the vaccine showed high immunogenicity and high levels of neutralizing antibodies (antibodies needed to successfully fight the virus), according to a press release. Researchers are hopeful the vaccine will also be successful in humans.

In Phase 1 of the trial, 130 healthy participants between the ages of 18 and 59 will be enrolled at two sites in Australia. Participants will receive either the vaccine or a placebo. The study will also test the vaccine with and without the Matrix-M™ adjuvant as well as in two dose sizes, 5 and 25 micrograms.

Phase 2 of the clinical trial is expected to take place in multiple countries, including the United States. It will continue to assess immune response and safety as well as COVID-19 disease reduction in a broader age range.

"Administering our vaccine in the first participants of this clinical trial is a significant achievement, bringing us one step closer toward addressing the fundamental need for a vaccine in the fight against the global COVID‑19 pandemic," said Stanley C. Erck, President and Chief Executive Officer of Novavax, in a press release.

The trial is being conducted in a Phase 1/2 approach that will allow for rapid advancement between the phases. Results from Phase 1 are expected in July 2020.

Read more about the vaccine trial.

Watch our latest HealthDay Now as we dive into the latest details on multisystem inflammatory syndrome in children (MIS-C).

Mabel Jong from our liveblog team speaks with Dr. Mary Beth Son, Program Director of Boston Children's Hospital's Rheumatology Program, and Brian Padla, father of James Padla, who has MIS-C.

Watch the in-depth discussion above, and see our past HealthDay Nows and other videos on our YouTube channel.


HD Live! Videos

Watch our latest HD Live! as we take a look at the global COVID-19 vaccination rollout and how the United States rollout compares.

Mabel Jong from our liveblog team speaks with Dr. Ran Balicer of Clalit Health Services and Dr. Arnold Monto of University of Michigan School of Public Health.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

UPDATE 1/26/21: Since our HD Live! interview with CEO Andrei Doroshin, the Philadelphia Health Department has severed its ties with the organization. The nonprofit has changed its status to a for-profit entity.

Watch our latest HD Live! as we take a look at Philly Fighting Covid, a nonprofit organization run by graduate students from Drexel University that aims to help with mass COVID-19 vaccination in Philadelphia.

Mabel Jong from our liveblog team speaks with Andrei Doroshin, founder of Philly Fighting Covid.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a deep dive into the vaccine rollout across the country.

Mabel Jong from our liveblog team speaks with Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota and a member of the Biden COVID-19 Advisory Board.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a deep dive into the latest information on the COVID-19 vaccines, including the rollout process, potential side effects, supply and distribution.

Mabel Jong from our liveblog team speaks with Dr. Paul Offit, Director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia and one of the physicians on the FDA Vaccines and Related Biological Products Advisory Committee.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! as we take a look back and a look ahead at COVID-19 and its impact on the United States and its healthcare workers.

Mabel Jong from our liveblog team speaks with Dr. David Shulkin, former Secretary of Veterans Affairs, ex-CEO of Beth Israel Medical Center in New York and an accomplished healthcare executive, and Dr. Joel Zivot, anesthesiologist and clinician at Emory University Hospital ICU.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Watch our latest HD Live! with Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID).

Mabel Jong from our liveblog team speaks with Dr. Anthony Fauci about the latest on COVID-19, including the vaccines, the infection rates and the future.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! is a conference wrap-up of the American Heart Association Scientific Sessions 2020.

Mabel Jong from our liveblog team speaks with Dr. Donald Lloyd-Jones, American Heart Association President-Elect, for a summary of the highlights of the AHA Scientific Sessions 2020.

Watch the in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.

Our latest HD Live! discussion is on how healthcare in America could be impacted by a Trump or Biden victory.

Mabel Jong from our liveblog team speaks with Marianne Udow-Phillips, director of the Center for Health and Research Transformation at the University of Michigan, and Brian Blase, who served as a healthcare adviser to President Trump from 2017-2019 and is now president and CEO of Blase Policy Strategies.

Watch our in-depth discussion above, and see our past HD Lives and other videos on our YouTube channel.